A Look at the Future of Biosimilars and What Physicians and Pharmacists Should Anticipate with Their Arrival on the U.S. Market (Part 1 of 2)

What this episode covers

Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 1: Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 2: Development of a VTE Risk Assessment Model and Protocol Jordan C. Messler, M.D., FHM Overview Venous thromboembolism (deep vein thrombosis, pulmonary embolism, or both) remains a significant threat to patient safety. At least 100,000 deaths are attributable to venous thromboembolism (VTE) each year in the United States. VTE is primarily a problem of hospitalized and recently-hospitalized patients. Although the majority of medical and surgical inpatients have multiple risk factors for VTE, evidence shows that only 30% to 50% of patients receive adequate prophylaxis. Barriers to the use of prophylaxis include lack of familiarity with published clinical guidelines, underestimation of VTE risk, concern over risk of bleeding from anticoagulants, and difficulty achieving hospital-wide implementation of risk assessment procedures. To improve inpatient safety, regulatory and professional organizations have endorsed practice guidelines for VTE prophylaxis. Current guidelines from the American College of Chest Physicians recommend that hospitals develop a formal strategy to prevent thromboembolic complications and, more specifically, provide prophylaxis in patients with VTE risk factors. This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants. Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout (PDF), which is included with the podcast. This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Distinct summary based on available episode metadata or transcript content.